The North America drug eluting cardiovascular devices market is expanding due to rising cardiovascular disease cases, growing preference for minimally invasive treatments, and increasing adoption of advanced interventional cardiology technologies. Strong healthcare infrastructure, continuous technological innovation, and the presence of major medical device companies are supporting market...